Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat + exemestane in HR+ HER2- advanced breast cancer after non-steroidal AI failure
CTR20171558Phase 3Active
- Sponsor
- Eden Biologics, Inc.
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of entinostat in breast cancer, sponsored by Eden Biologics, Inc.. Started Apr 2018; status: active.
02
Drugs
entinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20171558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171558.